APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Digital Therapeutics Platforms

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Digital Therapeutics Platforms Market Analysis and Forecast 2026-2032

Report ID 17411893026 March 2026218 pages

Choose your research edition.

Industry ResearchDigital Therapeutics Platforms Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Digital Therapeutics Platforms Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Digital Therapeutics Platforms Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Digital Therapeutics Platforms Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Digital Therapeutics Platforms Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global Digital Therapeutics Platforms market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Digital Therapeutics Platforms is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Digital Therapeutics Platforms is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Digital Therapeutics Platforms is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Digital Therapeutics Platforms is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Digital Therapeutics Platforms include Akili Interactive, DarioHealth, Teladoc Health, Voluntis, Sidekick Health, WellDoc, Talkspace, CogniFit and Tata Elxsi, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Digital Therapeutics Platforms, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Digital Therapeutics Platforms, also provides the revenue of main regions and countries. Of the upcoming market potential for Digital Therapeutics Platforms, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Digital Therapeutics Platforms revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Digital Therapeutics Platforms market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Digital Therapeutics Platforms revenue, projected growth trends, production technology, application and end-user industry.

Digital Therapeutics Platforms Segment by Company

Akili Interactive

DarioHealth

Teladoc Health

Voluntis

Sidekick Health

WellDoc

Talkspace

CogniFit

Tata Elxsi

Mahalo Health

2Morrow

Omada Health

Click Therapeutics

Orexo

ResMed

Virta Health

Bifourmis

SilverCloud (Amwell)

Noom

Big Health

Kaia Health

Cognoa

Headspace Health

CureApp

Calm Health

Riva Health

Sweetch-Health

Lark Health

Vida Health

Mahana Therapeutics

Blue Note Therapeutics

Lyra Health

Modern Health

Canary Health

Virgin Pulse

Slanhealth

Best Covered

Dami and Xiaomi

WeiMai

Jianhai Tech

Digital Therapeutics Platforms Segment by Type

Chronic Disease Digital Therapeutics

Psychiatric Disorders Digital Therapeutics

Quit Smoking Digital Therapeutics

Sleep Disorders and Respiratory Diseases Digital Therapeutics

Others

Digital Therapeutics Platforms Segment by Application

Enterprise

Personal

Digital Therapeutics Platforms Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Therapeutics Platforms market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Digital Therapeutics Platforms and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Therapeutics Platforms.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Digital Therapeutics Platforms in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Digital Therapeutics Platforms company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Digital Therapeutics Platforms revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Digital Therapeutics Platforms Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Chronic Disease Digital Therapeutics Major Player Table 3. Psychiatric Disorders Digital Therapeutics Major Player Table 4. Quit Smoking Digital Therapeutics Major Player Table 5. Sleep Disorders and Respiratory Diseases Digital Therapeutics Major Player Table 6. Others Major Player Table 7. Global Digital Therapeutics Platforms Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Enterprise Major Player Table 9. Personal Major Player Table 10. Digital Therapeutics Platforms Industry Trends Table 11. Digital Therapeutics Platforms Industry Drivers Table 12. Digital Therapeutics Platforms Industry Opportunities and Challenges Table 13. Digital Therapeutics Platforms Industry Restraints Table 14. Global Digital Therapeutics Platforms Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Digital Therapeutics Platforms Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Digital Therapeutics Platforms Market Share by Region (2021-2026) Table 17. Global Digital Therapeutics Platforms Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Digital Therapeutics Platforms Market Share by Region (2027-2032) Table 19. Global Digital Therapeutics Platforms Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Digital Therapeutics Platforms Revenue Market Share by Players (2021-2026) Table 21. Global Digital Therapeutics Platforms Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Digital Therapeutics Platforms Key Players Headquarters & Area Served Table 23. Global Digital Therapeutics Platforms Players, Product Type & Application Table 24. Global Digital Therapeutics Platforms Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Digital Therapeutics Platforms by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Digital Therapeutics Platforms Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Digital Therapeutics Platforms Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Digital Therapeutics Platforms Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Digital Therapeutics Platforms Revenue Market Share by Type (2021-2026) Table 31. Global Digital Therapeutics Platforms Revenue Market Share by Type (2027-2032) Table 32. Global Digital Therapeutics Platforms Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Digital Therapeutics Platforms Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Digital Therapeutics Platforms Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Digital Therapeutics Platforms Revenue Market Share by Application (2021-2026) Table 36. Global Digital Therapeutics Platforms Revenue Market Share by Application (2027-2032) Table 37. Akili Interactive Company Information Table 38. Akili Interactive Business Overview Table 39. Akili Interactive Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Akili Interactive Digital Therapeutics Platforms Product Portfolio Table 41. Akili Interactive Recent Development Table 42. DarioHealth Company Information Table 43. DarioHealth Business Overview Table 44. DarioHealth Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. DarioHealth Digital Therapeutics Platforms Product Portfolio Table 46. DarioHealth Recent Development Table 47. Teladoc Health Company Information Table 48. Teladoc Health Business Overview Table 49. Teladoc Health Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Teladoc Health Digital Therapeutics Platforms Product Portfolio Table 51. Teladoc Health Recent Development Table 52. Voluntis Company Information Table 53. Voluntis Business Overview Table 54. Voluntis Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Voluntis Digital Therapeutics Platforms Product Portfolio Table 56. Voluntis Recent Development Table 57. Sidekick Health Company Information Table 58. Sidekick Health Business Overview Table 59. Sidekick Health Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Sidekick Health Digital Therapeutics Platforms Product Portfolio Table 61. Sidekick Health Recent Development Table 62. WellDoc Company Information Table 63. WellDoc Business Overview Table 64. WellDoc Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. WellDoc Digital Therapeutics Platforms Product Portfolio Table 66. WellDoc Recent Development Table 67. Talkspace Company Information Table 68. Talkspace Business Overview Table 69. Talkspace Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Talkspace Digital Therapeutics Platforms Product Portfolio Table 71. Talkspace Recent Development Table 72. CogniFit Company Information Table 73. CogniFit Business Overview Table 74. CogniFit Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. CogniFit Digital Therapeutics Platforms Product Portfolio Table 76. CogniFit Recent Development Table 77. Tata Elxsi Company Information Table 78. Tata Elxsi Business Overview Table 79. Tata Elxsi Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Tata Elxsi Digital Therapeutics Platforms Product Portfolio Table 81. Tata Elxsi Recent Development Table 82. Mahalo Health Company Information Table 83. Mahalo Health Business Overview Table 84. Mahalo Health Digital Therapeutics Platforms Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Mahalo Health Digital Therapeutics Platforms Product Portfolio Table 86. Mahalo Health Recent Development Table 87. 2Morrow Company Information Table 88. 2Morrow Business Overview Table 89. 2Morrow Digital Therapeutics Platforms Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. 2Morrow Digital Therapeutics Platforms Product Portfolio Table 91. 2Morrow Recent Development Table 92. Omada Health Company Information Table 93. Omada Health Business Overview Table 94. Omada Health Digital Therapeutics Platforms Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Omada Health Digital Therapeutics Platforms Product Portfolio Table 96. Omada Health Recent Development Table 97. Click Therapeutics Company Information Table 98. Click Therapeutics Business Overview Table 99. Click Therapeutics Digital Therapeutics Platforms Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Click Therapeutics Digital Therapeutics Platforms Product Portfolio Table 101. Click Therapeutics Recent Development Table 102. Orexo Company Information Table 103. Orexo Business Overview Table 104. Orexo Digital Therapeutics Platforms Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Orexo Digital Therapeutics Platforms Product Portfolio Table 106. Orexo Recent Development Table 107. ResMed Company Information Table 108. ResMed Business Overview Table 109. ResMed Digital Therapeutics Platforms Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. ResMed Digital Therapeutics Platforms Product Portfolio Table 111. ResMed Recent Development Table 112. Virta Health Company Information Table 113. Virta Health Business Overview Table 114. Virta Health Digital Therapeutics Platforms Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Virta Health Digital Therapeutics Platforms Product Portfolio Table 116. Virta Health Recent Development Table 117. Bifourmis Company Information Table 118. Bifourmis Business Overview Table 119. Bifourmis Digital Therapeutics Platforms Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Bifourmis Digital Therapeutics Platforms Product Portfolio Table 121. Bifourmis Recent Development Table 122. SilverCloud (Amwell) Company Information Table 123. SilverCloud (Amwell) Business Overview Table 124. SilverCloud (Amwell) Digital Therapeutics Platforms Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. SilverCloud (Amwell) Digital Therapeutics Platforms Product Portfolio Table 126. SilverCloud (Amwell) Recent Development Table 127. Noom Company Information Table 128. Noom Business Overview Table 129. Noom Digital Therapeutics Platforms Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Noom Digital Therapeutics Platforms Product Portfolio Table 131. Noom Recent Development Table 132. Big Health Company Information Table 133. Big Health Business Overview Table 134. Big Health Digital Therapeutics Platforms Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Big Health Digital Therapeutics Platforms Product Portfolio Table 136. Big Health Recent Development Table 137. Kaia Health Company Information Table 138. Kaia Health Business Overview Table 139. Kaia Health Digital Therapeutics Platforms Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. Kaia Health Digital Therapeutics Platforms Product Portfolio Table 141. Kaia Health Recent Development Table 142. Cognoa Company Information Table 143. Cognoa Business Overview Table 144. Cognoa Digital Therapeutics Platforms Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. Cognoa Digital Therapeutics Platforms Product Portfolio Table 146. Cognoa Recent Development Table 147. Headspace Health Company Information Table 148. Headspace Health Business Overview Table 149. Headspace Health Digital Therapeutics Platforms Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 150. Headspace Health Digital Therapeutics Platforms Product Portfolio Table 151. Headspace Health Recent Development Table 152. CureApp Company Information Table 153. CureApp Business Overview Table 154. CureApp Digital Therapeutics Platforms Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 155. CureApp Digital Therapeutics Platforms Product Portfolio Table 156. CureApp Recent Development Table 157. Calm Health Company Information Table 158. Calm Health Business Overview Table 159. Calm Health Digital Therapeutics Platforms Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 160. Calm Health Digital Therapeutics Platforms Product Portfolio Table 161. Calm Health Recent Development Table 162. Riva Health Company Information Table 163. Riva Health Business Overview Table 164. Riva Health Digital Therapeutics Platforms Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 165. Riva Health Digital Therapeutics Platforms Product Portfolio Table 166. Riva Health Recent Development Table 167. Sweetch-Health Company Information Table 168. Sweetch-Health Business Overview Table 169. Sweetch-Health Digital Therapeutics Platforms Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 170. Sweetch-Health Digital Therapeutics Platforms Product Portfolio Table 171. Sweetch-Health Recent Development Table 172. Lark Health Company Information Table 173. Lark Health Business Overview Table 174. Lark Health Digital Therapeutics Platforms Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 175. Lark Health Digital Therapeutics Platforms Product Portfolio Table 176. Lark Health Recent Development Table 177. Vida Health Company Information Table 178. Vida Health Business Overview Table 179. Vida Health Digital Therapeutics Platforms Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 180. Vida Health Digital Therapeutics Platforms Product Portfolio Table 181. Vida Health Recent Development Table 182. Mahana Therapeutics Company Information Table 183. Mahana Therapeutics Business Overview Table 184. Mahana Therapeutics Digital Therapeutics Platforms Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 185. Mahana Therapeutics Digital Therapeutics Platforms Product Portfolio Table 186. Mahana Therapeutics Recent Development Table 187. Blue Note Therapeutics Company Information Table 188. Blue Note Therapeutics Business Overview Table 189. Blue Note Therapeutics Digital Therapeutics Platforms Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 190. Blue Note Therapeutics Digital Therapeutics Platforms Product Portfolio Table 191. Blue Note Therapeutics Recent Development Table 192. Lyra Health Company Information Table 193. Lyra Health Business Overview Table 194. Lyra Health Digital Therapeutics Platforms Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 195. Lyra Health Digital Therapeutics Platforms Product Portfolio Table 196. Lyra Health Recent Development Table 197. Modern Health Company Information Table 198. Modern Health Business Overview Table 199. Modern Health Digital Therapeutics Platforms Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 200. Modern Health Digital Therapeutics Platforms Product Portfolio Table 201. Modern Health Recent Development Table 202. Canary Health Company Information Table 203. Canary Health Business Overview Table 204. Canary Health Digital Therapeutics Platforms Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 205. Canary Health Digital Therapeutics Platforms Product Portfolio Table 206. Canary Health Recent Development Table 207. Virgin Pulse Company Information Table 208. Virgin Pulse Business Overview Table 209. Virgin Pulse Digital Therapeutics Platforms Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 210. Virgin Pulse Digital Therapeutics Platforms Product Portfolio Table 211. Virgin Pulse Recent Development Table 212. Slanhealth Company Information Table 213. Slanhealth Business Overview Table 214. Slanhealth Digital Therapeutics Platforms Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 215. Slanhealth Digital Therapeutics Platforms Product Portfolio Table 216. Slanhealth Recent Development Table 217. Best Covered Company Information Table 218. Best Covered Business Overview Table 219. Best Covered Digital Therapeutics Platforms Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 220. Best Covered Digital Therapeutics Platforms Product Portfolio Table 221. Best Covered Recent Development Table 222. Dami and Xiaomi Company Information Table 223. Dami and Xiaomi Business Overview Table 224. Dami and Xiaomi Digital Therapeutics Platforms Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 225. Dami and Xiaomi Digital Therapeutics Platforms Product Portfolio Table 226. Dami and Xiaomi Recent Development Table 227. WeiMai Company Information Table 228. WeiMai Business Overview Table 229. WeiMai Digital Therapeutics Platforms Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 230. WeiMai Digital Therapeutics Platforms Product Portfolio Table 231. WeiMai Recent Development Table 232. Jianhai Tech Company Information Table 233. Jianhai Tech Business Overview Table 234. Jianhai Tech Digital Therapeutics Platforms Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 235. Jianhai Tech Digital Therapeutics Platforms Product Portfolio Table 236. Jianhai Tech Recent Development Table 237. North America Digital Therapeutics Platforms Revenue by Type (2021-2026) & (US$ Million) Table 238. North America Digital Therapeutics Platforms Revenue by Type (2027-2032) & (US$ Million) Table 239. North America Digital Therapeutics Platforms Revenue by Application (2021-2026) & (US$ Million) Table 240. North America Digital Therapeutics Platforms Revenue by Application (2027-2032) & (US$ Million) Table 241. North America Digital Therapeutics Platforms Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 242. North America Digital Therapeutics Platforms Revenue by Country (2021-2026) & (US$ Million) Table 243. North America Digital Therapeutics Platforms Revenue by Country (US$ Million) & (2027-2032) Table 244. Europe Digital Therapeutics Platforms Revenue by Type (2021-2026) & (US$ Million) Table 245. Europe Digital Therapeutics Platforms Revenue by Type (2027-2032) & (US$ Million) Table 246. Europe Digital Therapeutics Platforms Revenue by Application (2021-2026) & (US$ Million) Table 247. Europe Digital Therapeutics Platforms Revenue by Application (2027-2032) & (US$ Million) Table 248. Europe Digital Therapeutics Platforms Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 249. Europe Digital Therapeutics Platforms Revenue by Country (2021-2026) & (US$ Million) Table 250. Europe Digital Therapeutics Platforms Revenue by Country (US$ Million) & (2027-2032) Table 251. China Digital Therapeutics Platforms Revenue by Type (2021-2026) & (US$ Million) Table 252. China Digital Therapeutics Platforms Revenue by Type (2027-2032) & (US$ Million) Table 253. China Digital Therapeutics Platforms Revenue by Application (2021-2026) & (US$ Million) Table 254. China Digital Therapeutics Platforms Revenue by Application (2027-2032) & (US$ Million) Table 255. Asia Digital Therapeutics Platforms Revenue by Type (2021-2026) & (US$ Million) Table 256. Asia Digital Therapeutics Platforms Revenue by Type (2027-2032) & (US$ Million) Table 257. Asia Digital Therapeutics Platforms Revenue by Application (2021-2026) & (US$ Million) Table 258. Asia Digital Therapeutics Platforms Revenue by Application (2027-2032) & (US$ Million) Table 259. Asia Digital Therapeutics Platforms Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 260. Asia Digital Therapeutics Platforms Revenue by Region (US$ Million) & (2021-2026) Table 261. Asia Digital Therapeutics Platforms Revenue by Region (US$ Million) & (2027-2032) Table 262. SAMEA Digital Therapeutics Platforms Revenue by Type (2021-2026) & (US$ Million) Table 263. SAMEA Digital Therapeutics Platforms Revenue by Type (2027-2032) & (US$ Million) Table 264. SAMEA Digital Therapeutics Platforms Revenue by Application (2021-2026) & (US$ Million) Table 265. SAMEA Digital Therapeutics Platforms Revenue by Application (2027-2032) & (US$ Million) Table 266. SAMEA Digital Therapeutics Platforms Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 267. SAMEA Digital Therapeutics Platforms Revenue by Country (2021-2026) & (US$ Million) Table 268. SAMEA Digital Therapeutics Platforms Revenue by Country (US$ Million) & (2027-2032) Table 269. Research Programs/Design for This Report Table 270. Authors List of This Report Table 271. Secondary Sources Table 272. Primary Sources List of Figures Figure 1. Digital Therapeutics Platforms Image Figure 2. Global Digital Therapeutics Platforms Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Digital Therapeutics Platforms Market Size Share 2021 VS 2025 VS 2032 Figure 4. Chronic Disease Digital Therapeutics Image Figure 5. Psychiatric Disorders Digital Therapeutics Image Figure 6. Quit Smoking Digital Therapeutics Image Figure 7. Sleep Disorders and Respiratory Diseases Digital Therapeutics Image Figure 8. Others Image Figure 9. Global Digital Therapeutics Platforms Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Digital Therapeutics Platforms Market Size Share 2021 VS 2025 VS 2032 Figure 11. Enterprise Image Figure 12. Personal Image Figure 13. Global Digital Therapeutics Platforms Market Size (US$ Million) & (2021-2032) Figure 14. Global Digital Therapeutics Platforms Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Digital Therapeutics Platforms Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Digital Therapeutics Platforms Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Digital Therapeutics Platforms Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Digital Therapeutics Platforms Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Digital Therapeutics Platforms Revenue Market Share by Type (2021-2032) Figure 21. Global Digital Therapeutics Platforms Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Digital Therapeutics Platforms Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Digital Therapeutics Platforms Revenue Market Share by Application (2021-2032) Figure 24. North America Digital Therapeutics Platforms Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Digital Therapeutics Platforms Revenue Share by Type (2021-2032) Figure 26. North America Digital Therapeutics Platforms Revenue Share by Application (2021-2032) Figure 27. North America Digital Therapeutics Platforms Revenue Share by Country (2021-2032) Figure 28. United States Digital Therapeutics Platforms Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Digital Therapeutics Platforms Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Digital Therapeutics Platforms Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Digital Therapeutics Platforms Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Digital Therapeutics Platforms Revenue Share by Type (2021-2032) Figure 33. Europe Digital Therapeutics Platforms Revenue Share by Application (2021-2032) Figure 34. Europe Digital Therapeutics Platforms Revenue Share by Country (2021-2032) Figure 35. Germany Digital Therapeutics Platforms Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Digital Therapeutics Platforms Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Digital Therapeutics Platforms Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Digital Therapeutics Platforms Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Digital Therapeutics Platforms Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Digital Therapeutics Platforms Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Digital Therapeutics Platforms Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Digital Therapeutics Platforms Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Digital Therapeutics Platforms Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Digital Therapeutics Platforms Revenue Share by Type (2021-2032) Figure 45. China Digital Therapeutics Platforms Revenue Share by Application (2021-2032) Figure 46. Asia Digital Therapeutics Platforms Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Digital Therapeutics Platforms Revenue Share by Type (2021-2032) Figure 48. Asia Digital Therapeutics Platforms Revenue Share by Application (2021-2032) Figure 49. Asia Digital Therapeutics Platforms Revenue Share by Region (2021-2032) Figure 50. Japan Digital Therapeutics Platforms Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Digital Therapeutics Platforms Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Digital Therapeutics Platforms Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Digital Therapeutics Platforms Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Digital Therapeutics Platforms Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Digital Therapeutics Platforms Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Digital Therapeutics Platforms Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Digital Therapeutics Platforms Revenue Share by Type (2021-2032) Figure 58. SAMEA Digital Therapeutics Platforms Revenue Share by Application (2021-2032) Figure 59. SAMEA Digital Therapeutics Platforms Revenue Share by Country (2021-2032) Figure 60. Brazil Digital Therapeutics Platforms Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Digital Therapeutics Platforms Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Digital Therapeutics Platforms Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Digital Therapeutics Platforms Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Digital Therapeutics Platforms Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Digital Therapeutics Platforms Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Digital Therapeutics Platforms Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Digital Therapeutics Platforms Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Digital Therapeutics Platforms Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Digital Therapeutics Platforms Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Digital Therapeutics Platforms Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Chronic Disease Digital Therapeutics
  • Psychiatric Disorders Digital Therapeutics
  • Quit Smoking Digital Therapeutics
  • Sleep Disorders and Respiratory Diseases Digital Therapeutics
  • Others
Applications
  • Enterprise
  • Personal
Companies covered
  • Akili Interactive
  • DarioHealth
  • Teladoc Health
  • Voluntis
  • Sidekick Health
  • WellDoc
  • Talkspace
  • CogniFit
  • Tata Elxsi
  • Mahalo Health
  • 2Morrow
  • Omada Health
  • Click Therapeutics
  • Orexo
  • ResMed
  • Virta Health
  • Bifourmis
  • SilverCloud (Amwell)
  • Noom
  • Big Health
  • Kaia Health
  • Cognoa
  • Headspace Health
  • CureApp
  • Calm Health
  • Riva Health
  • Sweetch-Health
  • Lark Health
  • Vida Health
  • Mahana Therapeutics
  • Blue Note Therapeutics
  • Lyra Health
  • Modern Health
  • Canary Health
  • Virgin Pulse
  • Slanhealth
  • Best Covered
  • Dami and Xiaomi
  • WeiMai
  • Jianhai Tech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Digital Therapeutics Platforms Market by Type
  3. 1.2.1 Global Digital Therapeutics Platforms Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Chronic Disease Digital Therapeutics
  5. 1.2.3 Psychiatric Disorders Digital Therapeutics
  6. 1.2.4 Quit Smoking Digital Therapeutics
  7. 1.2.5 Sleep Disorders and Respiratory Diseases Digital Therapeutics
  8. 1.2.6 Others
  9. 1.3 Digital Therapeutics Platforms Market by Application
  10. 1.3.1 Global Digital Therapeutics Platforms Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Enterprise
  12. 1.3.3 Personal
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Digital Therapeutics Platforms Market Dynamics
  1. 2.1 Digital Therapeutics Platforms Industry Trends
  2. 2.2 Digital Therapeutics Platforms Industry Drivers
  3. 2.3 Digital Therapeutics Platforms Industry Opportunities and Challenges
  4. 2.4 Digital Therapeutics Platforms Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Digital Therapeutics Platforms Market Perspective (2021-2032)
  2. 3.2 Global Digital Therapeutics Platforms Growth Trends by Region
  3. 3.2.1 Global Digital Therapeutics Platforms Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Digital Therapeutics Platforms Market Size by Region (2021-2026)
  5. 3.2.3 Global Digital Therapeutics Platforms Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Digital Therapeutics Platforms Revenue by Players
  2. 4.1.1 Global Digital Therapeutics Platforms Revenue by Players (2021-2026)
  3. 4.1.2 Global Digital Therapeutics Platforms Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Digital Therapeutics Platforms Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Digital Therapeutics Platforms Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Digital Therapeutics Platforms Key Players Headquarters & Area Served
  7. 4.4 Global Digital Therapeutics Platforms Players, Product Type & Application
  8. 4.5 Global Digital Therapeutics Platforms Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Digital Therapeutics Platforms Market CR5 and HHI
  11. 4.6.3 2025 Digital Therapeutics Platforms Tier 1, Tier 2, and Tier 3
5 Digital Therapeutics Platforms Market Size by Type
  1. 5.1 Global Digital Therapeutics Platforms Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Digital Therapeutics Platforms Revenue by Type (2021-2032)
  3. 5.3 Global Digital Therapeutics Platforms Revenue Market Share by Type (2021-2032)
6 Digital Therapeutics Platforms Market Size by Application
  1. 6.1 Global Digital Therapeutics Platforms Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Digital Therapeutics Platforms Revenue by Application (2021-2032)
  3. 6.3 Global Digital Therapeutics Platforms Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Akili Interactive
  2. 7.1.1 Akili Interactive Company Information
  3. 7.1.2 Akili Interactive Business Overview
  4. 7.1.3 Akili Interactive Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Akili Interactive Digital Therapeutics Platforms Product Portfolio
  6. 7.1.5 Akili Interactive Recent Developments
  7. 7.2 DarioHealth
  8. 7.2.1 DarioHealth Company Information
  9. 7.2.2 DarioHealth Business Overview
  10. 7.2.3 DarioHealth Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  11. 7.2.4 DarioHealth Digital Therapeutics Platforms Product Portfolio
  12. 7.2.5 DarioHealth Recent Developments
  13. 7.3 Teladoc Health
  14. 7.3.1 Teladoc Health Company Information
  15. 7.3.2 Teladoc Health Business Overview
  16. 7.3.3 Teladoc Health Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Teladoc Health Digital Therapeutics Platforms Product Portfolio
  18. 7.3.5 Teladoc Health Recent Developments
  19. 7.4 Voluntis
  20. 7.4.1 Voluntis Company Information
  21. 7.4.2 Voluntis Business Overview
  22. 7.4.3 Voluntis Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Voluntis Digital Therapeutics Platforms Product Portfolio
  24. 7.4.5 Voluntis Recent Developments
  25. 7.5 Sidekick Health
  26. 7.5.1 Sidekick Health Company Information
  27. 7.5.2 Sidekick Health Business Overview
  28. 7.5.3 Sidekick Health Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Sidekick Health Digital Therapeutics Platforms Product Portfolio
  30. 7.5.5 Sidekick Health Recent Developments
  31. 7.6 WellDoc
  32. 7.6.1 WellDoc Company Information
  33. 7.6.2 WellDoc Business Overview
  34. 7.6.3 WellDoc Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  35. 7.6.4 WellDoc Digital Therapeutics Platforms Product Portfolio
  36. 7.6.5 WellDoc Recent Developments
  37. 7.7 Talkspace
  38. 7.7.1 Talkspace Company Information
  39. 7.7.2 Talkspace Business Overview
  40. 7.7.3 Talkspace Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Talkspace Digital Therapeutics Platforms Product Portfolio
  42. 7.7.5 Talkspace Recent Developments
  43. 7.8 CogniFit
  44. 7.8.1 CogniFit Company Information
  45. 7.8.2 CogniFit Business Overview
  46. 7.8.3 CogniFit Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  47. 7.8.4 CogniFit Digital Therapeutics Platforms Product Portfolio
  48. 7.8.5 CogniFit Recent Developments
  49. 7.9 Tata Elxsi
  50. 7.9.1 Tata Elxsi Company Information
  51. 7.9.2 Tata Elxsi Business Overview
  52. 7.9.3 Tata Elxsi Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Tata Elxsi Digital Therapeutics Platforms Product Portfolio
  54. 7.9.5 Tata Elxsi Recent Developments
  55. 7.10 Mahalo Health
  56. 7.10.1 Mahalo Health Company Information
  57. 7.10.2 Mahalo Health Business Overview
  58. 7.10.3 Mahalo Health Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Mahalo Health Digital Therapeutics Platforms Product Portfolio
  60. 7.10.5 Mahalo Health Recent Developments
  61. 7.11 2Morrow
  62. 7.11.1 2Morrow Company Information
  63. 7.11.2 2Morrow Business Overview
  64. 7.11.3 2Morrow Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  65. 7.11.4 2Morrow Digital Therapeutics Platforms Product Portfolio
  66. 7.11.5 2Morrow Recent Developments
  67. 7.12 Omada Health
  68. 7.12.1 Omada Health Company Information
  69. 7.12.2 Omada Health Business Overview
  70. 7.12.3 Omada Health Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Omada Health Digital Therapeutics Platforms Product Portfolio
  72. 7.12.5 Omada Health Recent Developments
  73. 7.13 Click Therapeutics
  74. 7.13.1 Click Therapeutics Company Information
  75. 7.13.2 Click Therapeutics Business Overview
  76. 7.13.3 Click Therapeutics Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Click Therapeutics Digital Therapeutics Platforms Product Portfolio
  78. 7.13.5 Click Therapeutics Recent Developments
  79. 7.14 Orexo
  80. 7.14.1 Orexo Company Information
  81. 7.14.2 Orexo Business Overview
  82. 7.14.3 Orexo Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Orexo Digital Therapeutics Platforms Product Portfolio
  84. 7.14.5 Orexo Recent Developments
  85. 7.15 ResMed
  86. 7.15.1 ResMed Company Information
  87. 7.15.2 ResMed Business Overview
  88. 7.15.3 ResMed Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  89. 7.15.4 ResMed Digital Therapeutics Platforms Product Portfolio
  90. 7.15.5 ResMed Recent Developments
  91. 7.16 Virta Health
  92. 7.16.1 Virta Health Company Information
  93. 7.16.2 Virta Health Business Overview
  94. 7.16.3 Virta Health Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Virta Health Digital Therapeutics Platforms Product Portfolio
  96. 7.16.5 Virta Health Recent Developments
  97. 7.17 Bifourmis
  98. 7.17.1 Bifourmis Company Information
  99. 7.17.2 Bifourmis Business Overview
  100. 7.17.3 Bifourmis Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Bifourmis Digital Therapeutics Platforms Product Portfolio
  102. 7.17.5 Bifourmis Recent Developments
  103. 7.18 SilverCloud (Amwell)
  104. 7.18.1 SilverCloud (Amwell) Company Information
  105. 7.18.2 SilverCloud (Amwell) Business Overview
  106. 7.18.3 SilverCloud (Amwell) Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  107. 7.18.4 SilverCloud (Amwell) Digital Therapeutics Platforms Product Portfolio
  108. 7.18.5 SilverCloud (Amwell) Recent Developments
  109. 7.19 Noom
  110. 7.19.1 Noom Company Information
  111. 7.19.2 Noom Business Overview
  112. 7.19.3 Noom Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Noom Digital Therapeutics Platforms Product Portfolio
  114. 7.19.5 Noom Recent Developments
  115. 7.20 Big Health
  116. 7.20.1 Big Health Company Information
  117. 7.20.2 Big Health Business Overview
  118. 7.20.3 Big Health Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Big Health Digital Therapeutics Platforms Product Portfolio
  120. 7.20.5 Big Health Recent Developments
  121. 7.21 Kaia Health
  122. 7.21.1 Kaia Health Company Information
  123. 7.21.2 Kaia Health Business Overview
  124. 7.21.3 Kaia Health Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Kaia Health Digital Therapeutics Platforms Product Portfolio
  126. 7.21.5 Kaia Health Recent Developments
  127. 7.22 Cognoa
  128. 7.22.1 Cognoa Company Information
  129. 7.22.2 Cognoa Business Overview
  130. 7.22.3 Cognoa Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  131. 7.22.4 Cognoa Digital Therapeutics Platforms Product Portfolio
  132. 7.22.5 Cognoa Recent Developments
  133. 7.23 Headspace Health
  134. 7.23.1 Headspace Health Company Information
  135. 7.23.2 Headspace Health Business Overview
  136. 7.23.3 Headspace Health Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  137. 7.23.4 Headspace Health Digital Therapeutics Platforms Product Portfolio
  138. 7.23.5 Headspace Health Recent Developments
  139. 7.24 CureApp
  140. 7.24.1 CureApp Company Information
  141. 7.24.2 CureApp Business Overview
  142. 7.24.3 CureApp Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  143. 7.24.4 CureApp Digital Therapeutics Platforms Product Portfolio
  144. 7.24.5 CureApp Recent Developments
  145. 7.25 Calm Health
  146. 7.25.1 Calm Health Company Information
  147. 7.25.2 Calm Health Business Overview
  148. 7.25.3 Calm Health Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  149. 7.25.4 Calm Health Digital Therapeutics Platforms Product Portfolio
  150. 7.25.5 Calm Health Recent Developments
  151. 7.26 Riva Health
  152. 7.26.1 Riva Health Company Information
  153. 7.26.2 Riva Health Business Overview
  154. 7.26.3 Riva Health Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  155. 7.26.4 Riva Health Digital Therapeutics Platforms Product Portfolio
  156. 7.26.5 Riva Health Recent Developments
  157. 7.27 Sweetch-Health
  158. 7.27.1 Sweetch-Health Company Information
  159. 7.27.2 Sweetch-Health Business Overview
  160. 7.27.3 Sweetch-Health Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  161. 7.27.4 Sweetch-Health Digital Therapeutics Platforms Product Portfolio
  162. 7.27.5 Sweetch-Health Recent Developments
  163. 7.28 Lark Health
  164. 7.28.1 Lark Health Company Information
  165. 7.28.2 Lark Health Business Overview
  166. 7.28.3 Lark Health Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  167. 7.28.4 Lark Health Digital Therapeutics Platforms Product Portfolio
  168. 7.28.5 Lark Health Recent Developments
  169. 7.29 Vida Health
  170. 7.29.1 Vida Health Company Information
  171. 7.29.2 Vida Health Business Overview
  172. 7.29.3 Vida Health Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  173. 7.29.4 Vida Health Digital Therapeutics Platforms Product Portfolio
  174. 7.29.5 Vida Health Recent Developments
  175. 7.30 Mahana Therapeutics
  176. 7.30.1 Mahana Therapeutics Company Information
  177. 7.30.2 Mahana Therapeutics Business Overview
  178. 7.30.3 Mahana Therapeutics Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  179. 7.30.4 Mahana Therapeutics Digital Therapeutics Platforms Product Portfolio
  180. 7.30.5 Mahana Therapeutics Recent Developments
  181. 7.31 Blue Note Therapeutics
  182. 7.31.1 Blue Note Therapeutics Company Information
  183. 7.31.2 Blue Note Therapeutics Business Overview
  184. 7.31.3 Blue Note Therapeutics Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  185. 7.31.4 Blue Note Therapeutics Digital Therapeutics Platforms Product Portfolio
  186. 7.31.5 Blue Note Therapeutics Recent Developments
  187. 7.32 Lyra Health
  188. 7.32.1 Lyra Health Company Information
  189. 7.32.2 Lyra Health Business Overview
  190. 7.32.3 Lyra Health Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  191. 7.32.4 Lyra Health Digital Therapeutics Platforms Product Portfolio
  192. 7.32.5 Lyra Health Recent Developments
  193. 7.33 Modern Health
  194. 7.33.1 Modern Health Company Information
  195. 7.33.2 Modern Health Business Overview
  196. 7.33.3 Modern Health Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  197. 7.33.4 Modern Health Digital Therapeutics Platforms Product Portfolio
  198. 7.33.5 Modern Health Recent Developments
  199. 7.34 Canary Health
  200. 7.34.1 Canary Health Company Information
  201. 7.34.2 Canary Health Business Overview
  202. 7.34.3 Canary Health Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  203. 7.34.4 Canary Health Digital Therapeutics Platforms Product Portfolio
  204. 7.34.5 Canary Health Recent Developments
  205. 7.35 Virgin Pulse
  206. 7.35.1 Virgin Pulse Company Information
  207. 7.35.2 Virgin Pulse Business Overview
  208. 7.35.3 Virgin Pulse Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  209. 7.35.4 Virgin Pulse Digital Therapeutics Platforms Product Portfolio
  210. 7.35.5 Virgin Pulse Recent Developments
  211. 7.36 Slanhealth
  212. 7.36.1 Slanhealth Company Information
  213. 7.36.2 Slanhealth Business Overview
  214. 7.36.3 Slanhealth Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  215. 7.36.4 Slanhealth Digital Therapeutics Platforms Product Portfolio
  216. 7.36.5 Slanhealth Recent Developments
  217. 7.37 Best Covered
  218. 7.37.1 Best Covered Company Information
  219. 7.37.2 Best Covered Business Overview
  220. 7.37.3 Best Covered Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  221. 7.37.4 Best Covered Digital Therapeutics Platforms Product Portfolio
  222. 7.37.5 Best Covered Recent Developments
  223. 7.38 Dami and Xiaomi
  224. 7.38.1 Dami and Xiaomi Company Information
  225. 7.38.2 Dami and Xiaomi Business Overview
  226. 7.38.3 Dami and Xiaomi Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  227. 7.38.4 Dami and Xiaomi Digital Therapeutics Platforms Product Portfolio
  228. 7.38.5 Dami and Xiaomi Recent Developments
  229. 7.39 WeiMai
  230. 7.39.1 WeiMai Company Information
  231. 7.39.2 WeiMai Business Overview
  232. 7.39.3 WeiMai Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  233. 7.39.4 WeiMai Digital Therapeutics Platforms Product Portfolio
  234. 7.39.5 WeiMai Recent Developments
  235. 7.40 Jianhai Tech
  236. 7.40.1 Jianhai Tech Company Information
  237. 7.40.2 Jianhai Tech Business Overview
  238. 7.40.3 Jianhai Tech Digital Therapeutics Platforms Revenue and Gross Margin (2021-2026)
  239. 7.40.4 Jianhai Tech Digital Therapeutics Platforms Product Portfolio
  240. 7.40.5 Jianhai Tech Recent Developments
8 North America
  1. 8.1 North America Digital Therapeutics Platforms Revenue (2021-2032)
  2. 8.2 North America Digital Therapeutics Platforms Revenue by Type (2021-2032)
  3. 8.2.1 North America Digital Therapeutics Platforms Revenue by Type (2021-2026)
  4. 8.2.2 North America Digital Therapeutics Platforms Revenue by Type (2027-2032)
  5. 8.3 North America Digital Therapeutics Platforms Revenue Share by Type (2021-2032)
  6. 8.4 North America Digital Therapeutics Platforms Revenue by Application (2021-2032)
  7. 8.4.1 North America Digital Therapeutics Platforms Revenue by Application (2021-2026)
  8. 8.4.2 North America Digital Therapeutics Platforms Revenue by Application (2027-2032)
  9. 8.5 North America Digital Therapeutics Platforms Revenue Share by Application (2021-2032)
  10. 8.6 North America Digital Therapeutics Platforms Revenue by Country
  11. 8.6.1 North America Digital Therapeutics Platforms Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Digital Therapeutics Platforms Revenue by Country (2021-2026)
  13. 8.6.3 North America Digital Therapeutics Platforms Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Digital Therapeutics Platforms Revenue (2021-2032)
  2. 9.2 Europe Digital Therapeutics Platforms Revenue by Type (2021-2032)
  3. 9.2.1 Europe Digital Therapeutics Platforms Revenue by Type (2021-2026)
  4. 9.2.2 Europe Digital Therapeutics Platforms Revenue by Type (2027-2032)
  5. 9.3 Europe Digital Therapeutics Platforms Revenue Share by Type (2021-2032)
  6. 9.4 Europe Digital Therapeutics Platforms Revenue by Application (2021-2032)
  7. 9.4.1 Europe Digital Therapeutics Platforms Revenue by Application (2021-2026)
  8. 9.4.2 Europe Digital Therapeutics Platforms Revenue by Application (2027-2032)
  9. 9.5 Europe Digital Therapeutics Platforms Revenue Share by Application (2021-2032)
  10. 9.6 Europe Digital Therapeutics Platforms Revenue by Country
  11. 9.6.1 Europe Digital Therapeutics Platforms Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Digital Therapeutics Platforms Revenue by Country (2021-2026)
  13. 9.6.3 Europe Digital Therapeutics Platforms Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Digital Therapeutics Platforms Revenue (2021-2032)
  2. 10.2 China Digital Therapeutics Platforms Revenue by Type (2021-2032)
  3. 10.2.1 China Digital Therapeutics Platforms Revenue by Type (2021-2026)
  4. 10.2.2 China Digital Therapeutics Platforms Revenue by Type (2027-2032)
  5. 10.3 China Digital Therapeutics Platforms Revenue Share by Type (2021-2032)
  6. 10.4 China Digital Therapeutics Platforms Revenue by Application (2021-2032)
  7. 10.4.1 China Digital Therapeutics Platforms Revenue by Application (2021-2026)
  8. 10.4.2 China Digital Therapeutics Platforms Revenue by Application (2027-2032)
  9. 10.5 China Digital Therapeutics Platforms Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Digital Therapeutics Platforms Revenue (2021-2032)
  2. 11.2 Asia Digital Therapeutics Platforms Revenue by Type (2021-2032)
  3. 11.2.1 Asia Digital Therapeutics Platforms Revenue by Type (2021-2026)
  4. 11.2.2 Asia Digital Therapeutics Platforms Revenue by Type (2027-2032)
  5. 11.3 Asia Digital Therapeutics Platforms Revenue Share by Type (2021-2032)
  6. 11.4 Asia Digital Therapeutics Platforms Revenue by Application (2021-2032)
  7. 11.4.1 Asia Digital Therapeutics Platforms Revenue by Application (2021-2026)
  8. 11.4.2 Asia Digital Therapeutics Platforms Revenue by Application (2027-2032)
  9. 11.5 Asia Digital Therapeutics Platforms Revenue Share by Application (2021-2032)
  10. 11.6 Asia Digital Therapeutics Platforms Revenue by Country
  11. 11.6.1 Asia Digital Therapeutics Platforms Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Digital Therapeutics Platforms Revenue by Country (2021-2026)
  13. 11.6.3 Asia Digital Therapeutics Platforms Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Digital Therapeutics Platforms Revenue (2021-2032)
  2. 12.2 SAMEA Digital Therapeutics Platforms Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Digital Therapeutics Platforms Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Digital Therapeutics Platforms Revenue by Type (2027-2032)
  5. 12.3 SAMEA Digital Therapeutics Platforms Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Digital Therapeutics Platforms Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Digital Therapeutics Platforms Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Digital Therapeutics Platforms Revenue by Application (2027-2032)
  9. 12.5 SAMEA Digital Therapeutics Platforms Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Digital Therapeutics Platforms Revenue by Country
  11. 12.6.1 SAMEA Digital Therapeutics Platforms Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Digital Therapeutics Platforms Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Digital Therapeutics Platforms Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst